Overview
Jeffrey Skolnik is a Hematologist and an Oncologist in King Of Prussia, Pennsylvania. His top areas of expertise are Glioma and Immune Thrombocytopenic Purpura (ITP).
His clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
210 Mall Blvd, King Of Prussia, PA 19406
3401 Civic Center Blvd, Philadelphia, PA 19104
Additional Areas of Focus
Dr. Skolnik has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Janet Kwiatkowski is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Kwiatkowski is highly rated in 14 conditions, according to our data. Her top areas of expertise are Hemolytic Anemia, Congenital Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Splenectomy.
Fox Chase Cancer Center
Daniel Geynisman is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Geynisman is highly rated in 18 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Rutgers Cancer Institute Of New Jersey
Matthew Matasar is a Hematologist and an Oncologist in New Brunswick, New Jersey. Dr. Matasar is highly rated in 26 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant. Dr. Matasar is currently accepting new patients.
Frequently Asked Questions about Dr. Jeffrey Skolnik
How do I make an appointment with Dr. Jeffrey Skolnik?
You can book an appointment with Dr. Jeffrey Skolnik by calling their office at 610-337-3232. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jeffrey Skolnik a top-rated expert for Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey Skolnik is classified as an Experienced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jeffrey Skolnik specialize in?
While Dr. Jeffrey Skolnik is a Hematology, they have specific expertise in Glioma, Immune Thrombocytopenic Purpura (ITP). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Jeffrey Skolnik participate in research or clinical trials?
Yes. Dr. Jeffrey Skolnik has published 23 articles and abstracts on conditions like Glioma. You can view a list of Dr. Jeffrey Skolnik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jeffrey Skolnik accept my insurance?
Dr. Jeffrey Skolnik accepts most major insurance plans, including Humana. We recommend calling the office directly at 610-337-3232 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers